Position in JNJ
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$5,971,424
+$2,045,790 QoQ
Shares Held
24,429
+28.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.20%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026MCF Advisors LLC holds $24,166,889 across 16 Drug Manufacturers - General names. JNJ ranks #1 (24.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
24,429 | $5,971,424 | |
| 2 | AMGN |
Amgen Inc
|
11,665 | $4,104,330 | |
| 3 | LLY |
ELI LILLY & Co
|
3,526 | $3,243,109 | |
| 4 | MRK |
Merck & Co., Inc.
|
24,309 | $2,924,129 | |
| 5 | ABBV |
AbbVie Inc.
|
13,037 | $2,835,417 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
19,974 | $2,783,776 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
16,168 | $980,589 | |
| 8 | PFE |
Pfizer Inc
|
32,618 | $915,913 |
All Filings in JNJ
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,971,424 | 24,429 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $3,925,634 | 18,969 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $2,903,677 | 15,660 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $2,207,389 | 14,451 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $2,383,286 | 14,371 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $2,169,300 | 15,000 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $2,292,824 | 14,148 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $2,085,849 | 14,271 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $2,243,291 | 14,181 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $2,471,476 | 15,768 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $2,015,093 | 12,938 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $1,858,955 | 11,231 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $1,755,530 | 11,326 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $2,053,556 | 11,625 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $1,919,643 | 11,751 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,018,998 | 11,374 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,946,871 | 10,985 | Shares | Sole | 2022-05-05 | |
| 2021-09-30 | $1,838,193 | 11,382 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,679,030 | 10,192 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,671,603 | 10,171 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,486,454 | 9,445 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $1,482,695 | 9,959 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,328,109 | 9,444 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $1,349,721 | 10,293 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||